Projects per year
Fingerprint Dive into the research topics where Tomasz (Tom) Beer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
docetaxel
Medicine & Life Sciences
Castration
Medicine & Life Sciences
Androgens
Medicine & Life Sciences
Prostate-Specific Antigen
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Calcitriol
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1976 2017
- 8 Finished
Resistance and Response Mechanisms to Prostate Cancer Therapy
5/1/06 → 3/31/11
Project: Research project
Prostatic Neoplasms
Transcriptome
Neoplasms
Therapeutics
Drug Therapy
Calcitriol
Vitamin D
Prostatic Neoplasms
Apoptosis
Genes
Hot Flashes
Acupuncture
Prostatic Neoplasms
Serotonin
Calcitonin Gene-Related Peptide
Prostatic Neoplasms
Research Personnel
Complementary Therapies
Molecular Medicine
Molecular Epidemiology
CALCITRIOL IN RECURRENT PROSTATE CANCER
Beer, T. (. & Henner, W.
9/30/99 → 9/29/03
Project: Research project
Calcitriol
Prostatic Neoplasms
Prostate-Specific Antigen
Neoplasms
Antineoplastic Agents
Research Output 2000 2019
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
Kapoor, R., Deek, M. P., McIntyre, R., Raman, N., Kummerlowe, M., Chen, I., Gaver, M., Wang, H., Denmeade, S., Lotan, T., Paller, C., Markowski, M., Carducci, M., Eisenberger, M., Beer, T. T., Song, D. Y., Deweese, T. L., Hearn, J. W., Greco, S., Deville, C. & 7 others, , Jun 13 2019, In : BMC cancer. 19, 1, 572.Research output: Contribution to journal › Article
Open Access
Salvage Therapy
Prostatectomy
Double-Blind Method
Prostatic Neoplasms
Radiotherapy
Combining options in metastatic prostate cancer
Kopp, R. & Beer, T. T., Jan 1 2019, In : Nature Reviews Urology.Research output: Contribution to journal › Comment/debate
Prostatic Neoplasms
docetaxel
Therapeutics
Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)
Ferrari, A. C., Alumkal, J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. T., Apr 15 2019, In : Clinical Cancer Research. 25, 8, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Castration
Epigenomics
Prostatic Neoplasms
Emotions
Research
3
Citations
(Scopus)
Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer
Ferrari, A. C., Alumkal, J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 52-63 12 p.Research output: Contribution to journal › Article
Castration
Epigenomics
Prostatic Neoplasms
Arm
Androgen Receptors
Erratum to: Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy (Nature Communications, (2018), 9, 1, (4972), 10.1038/s41467-018-07411-7)
Geng, H., Xue, C., Mendonca, J., Sun, X-X., Liu, Q., Reardon, P. N., Chen, Y., Qian, K., Hua, V., Chen, A., Pan, F., Yuan, J., Dang, S., Beer, T. T., Dai, M., Kachhap, S. K. & Qian, Z. D., Dec 1 2019, In : Nature Communications. 10, 1, 164.Research output: Contribution to journal › Comment/debate
hypoxia
Androgens
therapy
switches
communication